← Back to Screener
Rafael Holdings, Inc. Class B Common Stock (RFL)
Price$1.55
Value ScoreC
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)23.43%
Price vs S&P 500 (4W)21.10%
VGM Score51.15
Market Capitalization$80.64M
All Metrics
Book Value / Share (Quarterly)$1.53
P/TBV (Annual)1.41x
Revenue Growth (3Y)30.78%
Cash Flow / Share (Quarterly)$-0.54
Price vs S&P 500 (YTD)23.20%
Gross Margin (TTM)93.12%
Net Profit Margin (TTM)-2846.60%
EPS (TTM)$-0.78
10-Day Avg Trading Volume0.08M
EPS Excl Extra (TTM)$-0.78
Revenue Growth (5Y)-28.51%
EPS (Annual)$-1.02
ROI (Annual)-32.10%
Gross Margin (Annual)85.39%
Net Profit Margin (5Y Avg)-8574.79%
Cash / Share (Quarterly)$0.73
Revenue Growth QoQ (YoY)174.03%
ROA (Last FY)-26.75%
Revenue Growth TTM (YoY)64.73%
EBITD / Share (TTM)$-0.82
ROE (5Y Avg)-44.04%
Operating Margin (TTM)-3044.20%
Cash Flow / Share (Annual)$-0.36
P/B Ratio1.02x
P/B Ratio (Quarterly)0.77x
Net Income / Employee (Annual)$-1,453,300
EV / Revenue (TTM)37.42x
Net Interest Coverage (TTM)-6.64x
ROA (TTM)-31.02%
EPS Incl Extra (Annual)$-1.02
Current Ratio (Annual)4.89x
Quick Ratio (Quarterly)3.08x
3-Month Avg Trading Volume0.08M
52-Week Price Return-3.73%
Revenue / Employee (TTM)$55,400
Tangible BV / Share (Quarterly)$0.90
P/S Ratio (Annual)87.93x
Asset Turnover (Annual)0.01x
52-Week High$3.19
Operating Margin (5Y Avg)-12541.74%
EPS Excl Extra (Annual)$-1.02
CapEx CAGR (5Y)-47.57%
Tangible BV CAGR (5Y)-11.70%
26-Week Price Return31.36%
Quick Ratio (Annual)4.71x
13-Week Price Return6.90%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)3.44x
Enterprise Value$43.52M
Revenue / Share Growth (5Y)-37.09%
Asset Turnover (TTM)0.01x
Book Value / Share Growth (5Y)-24.57%
Revenue / Employee (Annual)$43,700
Pretax Margin (Annual)-3620.07%
Cash / Share (Annual)$1.01
3-Month Return Std Dev52.08%
Net Income / Employee (TTM)$-1,576,500
ROE (Last FY)-32.33%
Net Interest Coverage (Annual)-1.88x
EPS Basic Excl Extra (Annual)$-1.02
Receivables Turnover (TTM)4.70x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.78
Receivables Turnover (Annual)1.74x
ROI (TTM)-38.72%
P/S Ratio (TTM)69.33x
Pretax Margin (5Y Avg)-10874.37%
Revenue / Share (Annual)$0.03
Tangible BV / Share (Annual)$1.18
Price vs S&P 500 (52W)-28.09%
Year-to-Date Return31.36%
5-Day Price Return11.51%
EPS Normalized (Annual)$-1.02
ROA (5Y Avg)-37.10%
Net Profit Margin (Annual)-3328.24%
Month-to-Date Return13.14%
Cash Flow / Share (TTM)$-0.36
EBITD / Share (Annual)$-0.97
Operating Margin (Annual)-3179.83%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-40.11%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.78
P/TBV (Quarterly)1.31x
P/B Ratio (Annual)0.92x
Pretax Margin (TTM)-2988.48%
Book Value / Share (Annual)$1.80
Price vs S&P 500 (13W)-1.36%
Beta0.49x
Revenue / Share (TTM)$0.02
ROE (TTM)-39.03%
52-Week Low$1.12
vGradeC
gGradeC
mGradeC
vgmGradeC
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
RFLRafael Holdings, Inc. Class B Common Stock | C | C | C | $1.55 |
| LLYEli Lilly & Co. | D | B | B | $1131.42 |
| JNJJohnson & Johnson | D | C | B | $232.77 |
| ABBVABBVIE INC. | D | C | C | $227.23 |
| MRKMerck & Co., Inc. | C | C | B | $120.79 |
| NVSNovartis AG | C | C | C | $149.16 |
| AZNAstraZeneca PLC | D | B | C | $185.95 |
| NVONovo-Nordisk A/S | B | B | B | $42.96 |
| ABTAbbott Laboratories | C | C | D | $91.07 |
| PFEPfizer Inc. | B | C | C | $26.04 |
| BMYBristol-Myers Squibb Co. | B | C | B | $57.27 |
About
Rafael Holdings is a biotechnology company with a lead asset, Trappsol Cyclo, in Phase 3 trials for Niemann-Pick Disease Type C1. The company pursues regulatory approval and commercialization while maintaining a diversified portfolio of clinical and early-stage pharmaceutical and medical device investments. Operations span three segments—healthcare, infusion technology, and real estate—with locations in the United States and Israel.